Mucosolvan Tropfen (Ambroxol Hydrochloride)

Ambroxol, the active ingredient in Mucosolvan Tropfen, is a mucolytic presented as an oral solution (drops) for oral use. It facilitates the clearance of thick bronchial secretions by reducing mucus viscosity, thereby easing productive cough in acute or chronic bronchitis, chronic obstructive pulmonary disease, and other upper respiratory tract infections.

GNH USA supplies Mucosolvan Tropfen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements through its global distribution network.

Ambroxol is used as an expectorant to improve mucus clearance in various respiratory conditions.

Acute or chronic bronchitis: reduces mucus viscosity to aid expectoration in patients with productive cough. Bronchopulmonary diseases with thick mucus: thins secretions to improve airway patency. Chronic obstructive pulmonary disease (COPD): assists in clearing mucus plugs and reducing cough frequency. Upper respiratory tract infections: supports mucus drainage to relieve congestion.

Common Side Effects: - Taste alteration: a transient bitter or salty taste in the mouth. - Nausea: mild gastrointestinal discomfort after dosing. - Abdominal discomfort: occasional stomach cramps or discomfort. - Diarrhea: loose stools occurring in a minority of users. - Skin rash: mild erythema or itching at the site of contact. - Dizziness: transient light‑headedness after administration.

Serious or Rare Side Effects: - Allergic reactions: hives, swelling, or anaphylaxis requiring immediate medical attention. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: abnormal liver function tests in rare cases. - Eosinophilia: increased eosinophil count indicating possible hypersensitivity. - Angioedema: rapid swelling of face, lips, or throat that may compromise breathing.

Before using Ambroxol, consider the following precautions.

Assess renal function: adjust use in patients with severe renal impairment. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Use with caution in asthma: monitor for bronchospasm. Monitor gastrointestinal tolerance: watch for nausea or diarrhea. Pregnancy and lactation: safety not established; use only if benefit outweighs risk. Store at room temperature: keep in the original container, protect from moisture and light.

Ambroxol may interact with other medicines; review the following.

Major Interactions (Avoid): - Antitussives that suppress cough (e.g., codeine): may counteract the expectorant effect. - Other mucolytics (e.g., N‑acetylcysteine): combined use can increase gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce secretion‑stimulating action of ambroxol. - Bronchodilators: generally safe but monitor for additive respiratory effects. - Warfarin: occasional reports of altered INR; check coagulation parameters if used together.